Searched for
PHARMA PRICES
From pharma to Scotch whisky, UK has "huge" export potential in India: Commerce Minister Piyush GoyalSpeaking at the India-UK JETCO Business Plenary on Monday, Goyal highlighted the complementary nature of the two economies and stressed the...- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
- Asset allocation: Gold leads as equity returns diverge in 2026 so farWelcome to TrendMap, your guide to the performance of different investment segments. In this edition, we present a 10-year performance trac...
- Nifty Outlook: Can bulls sustain recovery after 8-week losing streak?Nifty's recent recovery has generated optimism, but a sustained close above key resistance is crucial for further gains. Analysts suggest a...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets ended lower on Wednesday as the Sensex fell 429 points and Nifty dropped over 173 points, snapping a two-session rally. Inve...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
- Bank stocks lift Indian markets as crude prices ease, RBI decision eyedThe Indian stock markets saw an upswing fueled by the performance of banking stocks amid falling oil prices. The Sensex and Nifty enjoyed s...
- Market wrap: Trent, BSE, Coal India, Tech Mahindra top gainers and losers on Nifty and Sensex on TuesdayFranklin India Small Cap Fund crossed Rs 14,000 crore in AUM, while a Rs 10,000 monthly SIP grew to nearly Rs 1.94 crore over 20 years. The...
- Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbathIn an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors ...
- Indices snap four-day losing streak as oil prices ease, positive global cuesIndian equity benchmarks recovered in Monday's session, breaking a four-day losing streak and reflecting positive global trends. The Sensex...
- 5 stocks with consistent score improvement and upside potential of up to 32% in 1 year, according to analystsFor the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...
- Stock Radar: Dr Lal PathLabs stock hits fresh record high in September; will the rally continue in October 2026?Dr Lal PathLabs Ltd has recently experienced a rally but could not maintain its peak price levels. Experts suggest that the stock may targe...
- Govt extends import price curbs on two pharma raw materialsThe Directorate General of Foreign Trade has announced an extension of the minimum import price validity period. This extension will apply ...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Two Trades for Today: 2 mid-cap pharma stocks, one for a rise of 6.2%, and the other for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Load More
